Johanna Anna Kremer Hovinga
Overview
Explore the profile of Johanna Anna Kremer Hovinga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec K, Broughton H, Schmidli F, Schneider J, et al.
Thromb Res
. 2023 Feb;
223:87-94.
PMID: 36724651
Introduction: The collected evidence on thrombophilia guidelines is scarce and data about their impact on clinical decisions are unknown. We aimed to investigate the adherence to thrombophilia testing guidelines, its...
2.
Tarasco E, von Krogh A, Hrdlickova R, Braschler T, Iwaniec T, Knobl P, et al.
Res Pract Thromb Haemost
. 2022 Oct;
6(7):e12814.
PMID: 36284639
Introduction: Severe COVID-19 is associated with an important increase of von Willebrand factor and mild lowering of ADAMTS13 activity that may, in the presence of a strong inflammatory reaction, increase...
3.
Mertins T, Nilius H, Boss R, Knuchel M, Signorell A, Huber C, et al.
Front Cardiovasc Med
. 2022 Aug;
9:963528.
PMID: 35990937
Background: Prevention of recurrent venous thromboembolism (VTE) is considered a main goal of VTE management. However, the extent to which physicians adhere to the recommendations from evidence-based guidelines is unknown....
4.
Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec K, Broughton H, Brodard J, Porret N, et al.
J Clin Med
. 2022 Jul;
11(14).
PMID: 35887951
(1) Background: Thrombophilia testing utility has remained controversial since its clinical introduction, because data on its influence on treatment decisions are limited. (2) Methods: We conducted a single-center retrospective cohort...
5.
Nilius H, Mertins T, Boss R, Knuchel M, Blozik E, Hovinga J, et al.
Front Cardiovasc Med
. 2021 Oct;
8:749342.
PMID: 34660749
Little is known about long-term survival after the initial treatment of venous thromboembolism (VTE). In a prospective cohort study, we aimed to assess the long-term mortality and key predictor variables...
6.
Esteves Pereira M, Bocksrucker C, Hovinga J, Mueller M, Daskalakis M, Taleghani B, et al.
Transfus Med Rev
. 2021 Feb;
35(2):125-134.
PMID: 33518429
The treatment of patients with acquired hemophilia is challenging due to life-threatening hemorrhages, delayed response, and adverse effects to immunosuppressive agents. Even though immunoadsorption (IA) rapidly removes autoantibodies against factor...